Is LeonaBio, Inc. Common Stock profitable?

LeonaBio, Inc. Common Stock is not currently profitable: it reported a net loss of $129.4M over the trailing twelve months.

What is LeonaBio, Inc. Common Stock's earnings per share?

LeonaBio, Inc. Common Stock's diluted EPS over the trailing twelve months is $-22.49.

Where does LeonaBio, Inc. Common Stock's income statement data come from?

Every line is extracted from LeonaBio, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

LeonaBio, Inc. Common Stock LONA Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Research and development	$11.26M+67.8%	$6.71M+138%	$2.83M-22.8%	$3.66M-14.9%	$4.3M-54.1%
General and administrative	$6.88M+82.8%	$3.77M-7.0%	$4.05M+11.5%	$3.63M-30.6%	$5.23M-15.5%
Total costs & expenses	$17.21M-78.1%	$78.57M+1,043%	$6.87M-5.7%	$7.29M-23.5%	$9.54M-38.7%
Operating income	-$17.21M+78.1%	-$78.57M-1,043%	-$6.87M+5.7%	-$7.29M+23.5%	-$9.54M+38.7%
Other income (expense), net	$586K+130%	$255K-3.0%	$263K-19.1%	$325K-17.3%	$393K-30.2%
Net income	-$32.95M+60.3%	-$82.89M-1,154%	-$6.61M+5.1%	-$6.97M+23.8%	-$9.14M+39.1%
Diluted earnings per share	-$1.73+90.8%	-$18.90-1,025%	-$1.68-833%	-$0.18+92.3%	-$2.34+39.4%
Basic earnings per share	-$1.73+90.8%	-$18.90-1,025%	-$1.68-833%	-$0.18+92.3%	-$2.34+39.4%
Weighted-average shares, diluted	19M+345%	4.3M+8.4%	3.9M-89.9%	39.1M+901%	3.9M+1.5%
Weighted-average shares, basic	19M+345%	4.3M+8.4%	3.9M-89.9%	39.1M+901%	3.9M+1.5%
Gain Loss From Milestone Liability Change In Fair Value	-$929K—	——	——	——	——
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$32.96M+60.2%	-$82.89M-1,154%	-$6.61M+5.1%	-$6.97M+23.9%	-$9.15M+39.0%
Insurance Recoveries	——	——	——	——	——
Settlement expense	——	——	——	——	——
Other income, net (Note 6)	$586K+130%	$255K-3.0%	$263K-19.1%	$325K-17.3%	$393K-30.2%
EBIT	-$17.21M+78.1%	-$78.57M-1,043%	-$6.87M+5.7%	-$7.29M+23.5%	-$9.54M+38.7%
EBITDA	-$16.98M+78.3%	-$78.32M-1,074%	-$6.67M+5.9%	-$7.09M+23.7%	-$9.29M+39.4%
EBITDA	-$16.98M+78.3%	-$78.32M-1,074%	-$6.67M+5.9%	-$7.09M+23.7%	-$9.29M+39.4%
EBIT	-$17.21M+78.1%	-$78.57M-1,043%	-$6.87M+5.7%	-$7.29M+23.5%	-$9.54M+38.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is LeonaBio, Inc. Common Stock profitable?: LeonaBio, Inc. Common Stock is not currently profitable: it reported a net loss of $129.4M over the trailing twelve months.
What is LeonaBio, Inc. Common Stock's earnings per share?: LeonaBio, Inc. Common Stock's diluted EPS over the trailing twelve months is $-22.49.
Where does LeonaBio, Inc. Common Stock's income statement data come from?: Every line is extracted from LeonaBio, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.